Bioenvision
Reports describe the most recent news from Bioenvision
Published in Health Business Week, February 16th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Bioenvision.
Report 1: Bioenvision, Inc., (BIVN) has completed the substantive work and analysis involved with finalizing the Marketing Authorization Application (MAA) to expand the Evoltra (clofarabine) label and is now involved with the administrative aspects of formally submitting the filing to the European Medicines Agency (EMeA) for the use of Evoltra in adult AML patients over 65 years and who are considered unsuitable for intensive therapy.
The formal submission of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-02-16)
More Articles from Health Business Week
- Acromegaly
Tercica reports NDA for Somatuline Autogel for acromegaly accepted for filing by U.S. FDA - Alzheimer Disease
New gene uncovered for Alzheimer disease - Angiology
ProRhythm initiates U.S. pivotal trial for HIFU ablation system - Antipsychotics
Evidence lacking to support many off-label uses of atypical antipsychotics - Appendicitis
AspenBio Pharma's appendicitis test shows strong early results - Avian Influenza
Carrington comments on bird flu pandemic, provides update on DelSite vaccine - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
